{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T05:55:24Z","timestamp":1769147724404,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.neurobiolaging.2018.05.011","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T10:31:55Z","timestamp":1526380315000},"page":"265.e1-265.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Evaluating the causality of novel sequence variants in the prion protein gene by example"],"prefix":"10.1016","volume":"71","author":[{"given":"Tze How","family":"Mok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1066-4938","authenticated-orcid":false,"given":"Carolin","family":"Koriath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zane","family":"Jaunmuktane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Joiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D.F.","family":"Wadsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laszlo L.P.","family":"Hosszu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Brandner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambereen","family":"Parvez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas Clement","family":"Truelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva L\u00f8bner","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romi","family":"Saha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Collinge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4326-1468","authenticated-orcid":false,"given":"Simon","family":"Mead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/0471142905.hg0720s76","article-title":"Predicting functional effect of human missense mutations using PolyPhen-2","author":"Adzhubei","year":"2013","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib2","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1073\/pnas.0809170106","article-title":"Crystal structure of human prion protein bound to a therapeutic antibody","volume":"106","author":"Antonyuk","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib3","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1099\/vir.0.007930-0","article-title":"Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins","volume":"90","author":"Asante","year":"2009","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib4","doi-asserted-by":"crossref","first-page":"e1004953","DOI":"10.1371\/journal.ppat.1004953","article-title":"Transmission properties of human PrP 102L prions challenge the relevance of mouse models of GSS","volume":"11","author":"Asante","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib5","doi-asserted-by":"crossref","first-page":"E1551","DOI":"10.1002\/humu.21281","article-title":"PRNP allelic series from 19 years of prion protein gene sequencing at the MRC prion unit","volume":"31","author":"Beck","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib6","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.2174\/15680266113136660169","article-title":"NMR structural studies of human cellular prion proteins","volume":"13","author":"Biljan","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature20415","article-title":"Mammalian prions and their wider relevance in neurodegenerative diseases","volume":"539","author":"Collinge","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","article-title":"Prion diseases of humans and animals: their causes and molecular basis","volume":"24","author":"Collinge","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0140-6736(99)05128-4","article-title":"Variant Creutzfeldt-Jakob disease","volume":"354","author":"Collinge","year":"1999","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib10","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1138718","article-title":"A\u00a0general model of prion strains and their pathogenicity","volume":"318","author":"Collinge","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib11","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1073\/pnas.0811457106","article-title":"Folding kinetics of the human prion protein probed by temperature jump","volume":"106","author":"Hart","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/brain\/awl013","article-title":"Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations","volume":"129","author":"Hill","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib13","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/brain\/awg125","article-title":"Molecular classification of sporadic Creutzfeldt-Jakob disease","volume":"126","author":"Hill","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A\u00a0general framework for estimating the relative pathogenicity of human genetic variants","volume":"46","author":"Kircher","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib15","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm","volume":"4","author":"Kumar","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib17","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1021\/bi982714g","article-title":"Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein","volume":"38","author":"Liemann","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.ejhg.5201544","article-title":"Prion disease genetics","volume":"14","author":"Mead","year":"2006","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib19","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1056\/NEJMoa1214747","article-title":"A\u00a0novel prion disease associated with diarrhea and autonomic neuropathy","volume":"369","author":"Mead","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrneurol.2014.263","article-title":"A\u00a0new prion disease: relationship with central and peripheral amyloidoses","volume":"11","author":"Mead","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib21","doi-asserted-by":"crossref","first-page":"322ra9","DOI":"10.1126\/scitranslmed.aad5169","article-title":"Quantifying prion disease penetrance using large population control cohorts","volume":"8","author":"Minikel","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1750-3639.2008.00187.x","article-title":"Inter-laboratory assessment of PrPSc typing in creutzfeldt-jakob disease: a Western blot study within the NeuroPrion consortium","volume":"19","author":"Parchi","year":"2009","journal-title":"Brain. Pathol."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib23","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2051-5960-1-8","article-title":"Filamentous white matter prion protein deposition is a distinctive feature of multiple inherited prion diseases","volume":"1","author":"Reiniger","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2990.2010.01129.x","article-title":"Review: contribution of transgenic models to understanding human prion disease","volume":"36","author":"Wadsworth","year":"2010","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib27","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1126\/science.1103932","article-title":"Human prion protein with valine 129 prevents expression of variant CJD phenotype","volume":"306","author":"Wadsworth","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00401-010-0735-5","article-title":"Molecular pathology of human prion disease","volume":"121","author":"Wadsworth","year":"2011","journal-title":"Acta. Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib29","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/brain\/awl076","article-title":"Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein","volume":"129","author":"Wadsworth","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-59745-234-2_14","article-title":"Molecular diagnosis of human prion disease","volume":"459","author":"Wadsworth","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(01)05403-4","article-title":"Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay","volume":"358","author":"Wadsworth","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2018.05.011_bib32","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458018301672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458018301672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:30:08Z","timestamp":1759318208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458018301672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":32,"alternative-id":["S0197458018301672"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.05.011","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the causality of novel sequence variants in the prion protein gene by example","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}